Home › Vitamin D Deficiency › NCT04355572
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
Recruiting
Who can join
Ages 13 to 21 · Women
Full eligibility criteria
Inclusion Criteria: \- Postmenarchal adolescent females aged 13-21 who meet modified Rotterdam criteria for PCOS, with a serum vitamin D level between 6-29 ng/mL. Exclusion Criteria: * Other causes for hyperandrogenism, * Chronic renal diseases, * Acquired or inherited calcium and vitamin D metabolic disorders.
About the study
This study is a double blind, placebo controlled, randomized trial of study subjects with PCOS and low vitamin D to 2 groups- placebo and vitamin D replacement. Participants and investigators will be blinded to treatment modality until the end of the trial period
What is being tested
- Vitamin D 4000IU daily (drug)
- Placebo (drug)
Sponsor: Yale University · Participants: 60 · Started: 2026-09
Contact the study team
- Alla Vash-Margita, MD · Phone: 203-785-4010
Official record on ClinicalTrials.gov — NCT04355572
Locations in the U.S.
| Connecticut | Yale New Haven Children's Hospital, New Haven |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.